Nafcillin Sodium

萘夫西林钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNafcillin Sodium
Drug Alias Name新青三乙氧萘青霉素nafcilina奈夫西林钠nafcillinenafcillinum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsStaphylococcal Infections
Approved Indications in ChinaStaphylococcal Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1965/10/11
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShanxi Taiyue Pharmaceutical Co Ltd
Inactive CompaniesWyeth-Ayerst
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CF06
Related LinksWikipediaDrugBankKEGG